| Literature DB >> 24041261 |
Murali Shyamsundar, Benjamin Attwood, Liza Keating, Andrew P Walden.
Abstract
The estimation of extra-vascular lung water (EVLW) is an essential component in the assessment of critically ill patients. EVLW is independently associated with mortality and its manipulation has been shown to improve outcome. Accurate assessment of lung water is possible with CT and MR imaging but these are impractical for real-time measurement in sick patients and have been superseded by single thermal dilution techniques. While useful, single thermo-dilution requires repeated calibration and is prone to error, suggesting a need for other monitoring methods. Traditionally the lung was not thought amenable to ultrasound examination owing to the high acoustic impedance of air; however, the identification of artefacts in diseased lung has led to increased use of ultrasound as a point of care investigation for both diagnosis and to monitor response to interventions. Following the initial description of B-lines in association with increased lung water, accumulating evidence has shown that they are a useful and responsive measure of the presence and dynamic changes in EVLW. Animal models have confirmed a correlation with lung gravimetry and the utility of B-lines has been demonstrated in many clinical situations and correlated against other established measures of EVLW. With increasing availability and expertise the role of ultrasound in estimating EVLW should be embedded in clinical practice and incorporated into clinical algorithms to aid decision making. This review looks at the evidence for ultrasound as a valid, easy to use, non-invasive point of care investigation to assess EVLW.Entities:
Mesh:
Year: 2013 PMID: 24041261 PMCID: PMC4057491 DOI: 10.1186/cc12710
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Figure 1A-lines. Characteristic lines parallel to pleural line as a consequence of ultrasound reverberation artefacts within the pleural space.
Figure 2B-lines. Radial lines emanating from the pleural lines due to reverberation artefacts of ultrasound within sub-pleural structures.
Summary of studies assessing the utility of B-line estimation in emergency medicine and cardiology
| Study | Patient group | Ultrasound exam technique | Comparator | Conclusion |
|---|---|---|---|---|
| Lichtenstein and Meziere [ | Acutely dyspnoeic patients ( | 3.0 MHz cardiac transducer Anterior - area bound by clavicle to diaphragm and sternum to AAL Lateral - area bound by armpit to diaphragm and AAL to PAL | Clinical, radiological, Echo | B-line artefact was seen in 100% of patients with pulmonary oedema and absent in 92% patients with COPD and 98.75% patients with normal lungs |
| Lichtenstein and Meziere [ | Acutely dyspnoeic patients ( | 5 MHz microconvex transducer 6 sites in each hemithorax divided in anterior, lateral and posterolateral | NA | Lung ultrasound can reliably distinguish asthma, COPD, oedema, pulmonary embolism, pneumothorax and consolidation |
| Jambrik | Cardiology/ pneumonology ( | 2.5 to 3.5 MHz cardiac transducer 2nd to 4th ICS in left hemithorax (to 5th ICS on the right) at parasternal, midclavicular, AAL, PAL | Chest X-ray | Strong co-relation between B-line count and radiological lung water score ( |
| Agricola | Cardiology ( | 1.8 to 3.6 MHz transducer 2nd to 4th ICS in left hemithorax (to 5th ICS on the right) at parasternal, midclavicular, AAL, PAL | Echo (LV systolic function, PCWP, PAP) | Positive linear correlations between baseline B-line count and baseline ejection fraction, sPAP and estimated PCWP. A similar co-relation of the difference between post-exercise and baseline B-line count with indices of LV systolic and diastolic dysfunction |
| Frassi | Cardiology ( | 2.5 to 3.5 MHz transducer 2nd to 4th ICS in left hemithorax (to 5th ICS on the right) at parasternal, midclavicular, AAL, PAL | Echo | Absence or presence of B-line predicted event-free survival (70% versus 19%, |
| Frassi | Chest pain/dyspnoea patients ( | 2.5 to 3.5 MHz transducer 2nd to 4th ICS in left hemithorax (to 5th ICS on the right) at parasternal, midclavicular, AAL, PAL | Echo | B-lines associated with acute cardiac failure, response to treatment, EDV, LA dimension, MR, TR ( |
| Gargani | Dyspnoea patients ( | 2.5 to 3.5 MHz transducer 2nd to 4th ICS in left hemithorax (to 5th ICS on the right) at parasternal, midclavicular, AAL, PAL | NT pro-BNP | B-line co-related to NT pro-BNP ( |
| Volpicelli [ | Unselected acute emergency medicine admissions ( | 3.5 MHz convex transducer 8 areas in total Anterior - from the sternum to the AAL Lateral - from the AAL to PAL Each zone was divided into upper and lower halves | Chest X-ray | Diffuse B lines had sensitivity of 85.7% and a specificity of 97.7% for diagnosing radiologic interstitial oedema and a sensitivity of 85.3% and a specificity of 96.8% for diagnosing |
| Volpicelli | Acute cardiac failure ( | 3.5 MHz convex transducer 11 areas - 3 anterior and 3 lateral on right side and 2 anterior and 3 lateral on left side | Chest X-ray NT pro-BNP | Significant resolution of B lines after treatment ( |
| Prosen | Acutely dyspnoeic patients ( | 8 areas in total Anterior - from the sternum to the AAL Lateral - from the AAL to PAL Each zone was divided into upper and lower halves | NT pro-BNP Clinical score | B-line was the strongest predictor of acute heart failure with 100% sensitivity, 95% specificity, 96% PPV and 100% negative NPV to diagnose cardiac failure. B-line can reliably exclude pulmonary related dyspnoea in patients with elevated BNP and a history of cardiac failure |
| Liteplo | Acutely dyspnoeic patients ( | 2-5 MHz transducer 8 areas in total Anterior - from the sternum to the AAL Lateral - from the AAL to PAL Each zone was divided into upper and lower halves | NT pro-BNP Clinical review | The presence of a completely positive test gave an infinite likelihood ratio for diagnosing congestive cardiac failure and a completely negative test gave a likelihood ratio of 0.22 (CI 0.06 to 0.8). |
AAL, anterior axillary line; AUC, area under the curve; CI, confidence interval; COPD, chronic obstructive pulmonary disease; EDV, end diastolic volume; EF, ejection fraction; ICS, intercostal space; LA, left atrium; LV, left ventricle; MR, mitral regurgitation; NA, not available; NPV, negative predictive value; NT pro-BNP, N-terminal pro-brain natriuretic peptide; NYHA, New York Heart Association; PAL, posterior axillary line; PAP, pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; PPV, positive predictive value; sPAP, systolic pulmonary artery pressure; TR, tricuspid regurgitation.